Outcomes of patients with thyroid nodules clinically tested using a combination of mutation and microRNA classification: Interim results of a clinical experience study

We report interim results of a multicenter registry study of patients with thyroid nodules indeterminate by cytology that underwent combined mutation (ThyGenX) and microRNA (ThyraMIR) testing in clinical practice.

We examined the likelihood at which patients avoided surgery and survived without developing malignancy given combined test results.

Scroll to Top